For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 0 | - | - | 0 |
| General and administrative expense | 4,832 | 6,103.5* | 5,872 | 5,469 |
| Rent expense | 400 | 58* | - | 0 |
| Professional and consulting fees | 7,919 | 12,052.5* | 4,203 | 4,950 |
| Total operating expenses | 13,151 | 18,214 | 10,075 | 10,419 |
| Operating loss | -13,151 | -18,214* | -10,075 | -10,419 |
| Interest expense | 2,727 | 2,521.5 | 1,891 | 1,246 |
| Total other income (expense) | -2,727 | -2,521.5* | -1,891 | -1,246 |
| Loss before income taxes | - | -20,735.5 | -11,966 | -11,665 |
| Income tax expense | 0 | - | - | 0 |
| Net loss | -15,878 | -20,735.5 | -11,966 | -11,665 |
| Basic EPS | 0 | -0 | 0 | 0 |
| Diluted EPS | - | -0 | 0 | 0 |
| Basic Average Shares | 83,548,469 | 83,548,469 | 83,548,469 | 83,548,469 |
| Diluted Average Shares | 83,548,469 | 83,548,469 | 83,548,469 | 83,548,469 |
Nu-Med Plus, Inc. (NUMD)
Nu-Med Plus, Inc. (NUMD)